VanEck Associates’s Arcosa ACA Stock Holding History
Bought
Maintained
Sold
Other funds holding ACA
NAMI
RA
VanEck Associates's ACA Position: Q2 2026 in Review
VanEck Associates increased its Arcosa (ACA) stake by 173% in Q2 2026, buying an estimated $15.5M and bringing the position to 196,528 shares worth $28.6M. The position accounts for 0.02% of the portfolio, ranked #387.
VanEck Associates first reported a position in ACA in Q4 2025 and has held it in 3 quarters since. 425 funds tracked by Wall St. Rank hold ACA as of Q2 2026.
- VanEck Associates held 196,528 shares of Arcosa worth $28.6M as of Q2 2026.
- VanEck Associates bought 124,410 Arcosa shares in Q2 2026, an estimated $15.5M.
- Arcosa made up 0.02% of VanEck Associates's portfolio in Q2 2026, its #387 holding.
- VanEck Associates first reported a position in Arcosa in Q4 2025 and has held it in 3 quarters since.
- 425 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.